ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 18 Mar 2024
Last Applicant/ Owned by
200 Technology Square, 2nd Floor
Cambridge
MA
02139
Serial Number
97486047 filed on 01st Jul 2022
Registration Number
N/A
Correspondent Address
Aaron Y. Silverstein
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
MRESTORE-SQ
Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccin Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
Class [005]
Pharmaceutical Products
vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological, and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations, all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of pharmaceuticals; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells
Class [001]
Chemical Products
lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders
Mark Details
Serial Number
No 97486047
Mark Type
No Service Mark
Attorney Docket Number
No 1942.509.11
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Mar 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| 18th Mar 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 30th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 30th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 30th Aug 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 30th Aug 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 30th Aug 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 15th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 10th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 10th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |